- Home
- GXO vs XENE Comparison
GXO vs XENE Comparison
Compare GXO & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GXO | XENE |
|---|---|---|
| Founded | 2021 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.2B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GXO | XENE |
|---|---|---|
| Price | $50.32 | $54.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 11 |
| Target Price | $67.91 | ★ $68.55 |
| AVG Volume (30 Days) | ★ 1.7M | 998.9K |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $13,178,000,000.00 | $311,000.00 |
| Revenue This Year | $6.81 | N/A |
| Revenue Next Year | $5.95 | $2,496.48 |
| P/E Ratio | $1,687.67 | ★ N/A |
| Revenue Growth | ★ 12.55 | N/A |
| 52 Week Low | $39.92 | $28.97 |
| 52 Week High | $66.85 | $62.91 |
Technical Indicators
Market Signals| Indicator | GXO | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 48.61 | 46.02 |
| Support Level | $48.87 | $52.90 |
| Resistance Level | $55.41 | $59.43 |
| Average True Range (ATR) | 1.51 | 1.48 |
| MACD | 0.39 | -0.10 |
| Stochastic Oscillator | 72.47 | 36.54 |
Price Performance
Historical ComparisonAbout GXO GXO Logistics Inc.
GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.